Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: A randomized controlled trial

British Journal of Dermatology

Volumn 171, Issue 5, 2014, Pages 1164-1171

  Rubel, D M ^a,b   Spelman, L ^c   Murrell, D F ^d,e   See, J A ^f   Hewitt, D ^g   Foley, P ^h,i,j   Bosc, C ^k   Kerob, D ^l   Kerrouche, N ^k   Wulf, H C ^m   Shumack, S ⁿ  

^a Woden Dermatology and Probity Medical Research   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c Specialist Connect   (Australia)

^d Kogarah   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f Central Sydney Laboratory Services   (Australia)

^g SKIN AND CANCER FOUNDATION AUSTRALIA   (Australia)

^h SKIN AND CANCER FOUNDATION   (Australia)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j ST VINCENT S HOSPITAL   (Australia)

^k Galderma R and D   (France)

^l Galderma International   (France)

^m UNIVERSITY OF COPENHAGEN   (Denmark)

ⁿ St George Dermatology and Skin Cancer Centre   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; AMINOLEVULINIC ACID; METHYL 5-AMINOLEVULINATE; OINTMENT; PHOTOSENSITIZING AGENT;

ACTINIC KERATOSIS; ADULT; AGED; ALTERNATIVE MEDICINE; APPLICATION SITE ERYTHEMA; ARTICLE; CONTROLLED STUDY; CREAM; DAYLIGHT PHOTODYNAMIC THERAPY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FACE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SATISFACTION; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCABIES; SCALP; SINGLE BLIND PROCEDURE; SKIN BLEEDING; SKIN BURNING SENSATION; SKIN EDEMA; SKIN IRRITATION; SKIN MANIFESTATION; SKIN PAIN; SWELLING; TREATMENT OUTCOME; TREATMENT RESPONSE; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; COMPARATIVE STUDY; FACIAL DERMATOSES; INTRADERMAL DRUG ADMINISTRATION; KERATOSIS, ACTINIC; OINTMENT; PAIN; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; PROSPECTIVE STUDY; SCALP DERMATOSES; VERY ELDERLY;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; FACIAL DERMATOSES; FEMALE; HUMANS; KERATOSIS, ACTINIC; MALE; OINTMENTS; PAIN; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; SCALP DERMATOSES; TREATMENT OUTCOME;

EID: 84911451266     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13138     Document Type: Article

References (14)

1. Sociedade Brasileira de Dermatologia. Data analysis of the Brazilian Society of Dermatology skin cancer prevention campaign, 1999 to 2005. An Bras Dermatol 2006; 81: 529-35.
2. Memon AA, Tomenson JA, Bothwell J, Friedmann PS,. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol 2000; 142: 1154-9.
3. Naldi L, Chatenoud L, Piccitto R, et al,. Prevalence of actinic keratoses and associated factors in a representative sample of the Italian adult population: results from the Prevalence of Actinic Keratoses Italian Study, 2003-2004. Arch Dermatol 2006; 142: 722-6.
4. Frost C, Green A,. Epidemiology of solar keratosis. Br J Dermatol 1994; 131: 455-64.
5. Morton CA, Szeimies RM, Sidoroff A, Braathen LR,. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications-actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol 2013; 27: 536-44.
6. de Berker D, McGregor JM, Hughes BR,; British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of actinic keratoses. Br J Dermatol 2007; 156: 222-30.
7. Angell-Petersen E, Sørensen R, Warloe T,. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Invest Dermatol 2006; 126: 265-71.
8. Kennedy JC, Pottier RH,. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol, B 1992; 14: 275-92.
9. Wiegell S, Hædersdal M, Philipsen P, et al,. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study. Br J Dermatol 2008; 158: 740-6.
10. Wiegell S, Haedersdal M, Eriksen P, Wulf H,. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial. Br J Dermatol 2009; 160: 1308-14.
11. Wiegell S, Fabricius S, Stender I, et al,. A randomized, multicentre study of directed daylight exposure times of 1 vs. 2 h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp. Br J Dermatol 2011; 164: 1083-90.
12. Braathen LR,. Daylight photodynamic therapy in private practice in Switzerland: gain without pain. Acta Derm Venereol 2012; 92: 652-3.
13. Wiegell SR, Wulf HC, Szeimies RM, et al,. Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology. J Eur Acad Dermatol Venereol 2012; 26: 673-9.
14. Wiegell SR, Fabricius S, Gniadecka M, et al,. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study. Br J Dermatol 2012; 166: 1327-32.